Population
Endothelioma cell lines transformed by polyoma virus middle T antigen and endothelioma-bearing syngeneic mice
Comparison
NOS inhibitor L-canavanine (in vivo) vs Nontransformed control cells (in vitro)
Design
Preclinical
Authors
Loading...
Hypothesis-generating for NOS inhibition in endothelial tumors; clinical translation remains untested.
NOS hyperactivity in mTa-transformed endothelial cells contributes to hemangioma development, which can be attenuated by NOS inhibition.
Ghigo et al. (1995) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: